ResearcherFujita Health UniversityNo recent work listed

Hideaki Iwama

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2629-1809; OpenAlex author ID A5109497045. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper

Papers 2

Is 6 Months the Optimal Duration of Adjuvant Chemotherapy for Pancreatic Cancer? Co-author DOI 10.21873/cdp.10258 ↗
Impact of the aberrant right hepatic artery on local recurrence of pancreatic ductal adenocarcinoma after pancreaticoduodenectomy. Co-author DOI 10.1016/j.surg.2022.02.010 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Etsuro Hatano · 2 shared papers, 2022–2023 · strength 0.38
- Paper Is 6 Months the Optimal Duration of Adjuvant Chemotherapy for Pancreatic Cancer? DOI 10.21873/cdp.10258 ↗
- Paper Impact of the aberrant right hepatic artery on local recurrence of pancreatic ductal adenocarcinoma after pancreaticodu… DOI 10.1016/j.surg.2022.02.010 ↗
Takayoshi Nakajima · 1 shared paper, 2022 · strength 0.16
- Paper Impact of the aberrant right hepatic artery on local recurrence of pancreatic ductal adenocarcinoma after pancreaticodu… DOI 10.1016/j.surg.2022.02.010 ↗
Naoki Yamanaka · 1 shared paper, 2022 · strength 0.16
- Paper Impact of the aberrant right hepatic artery on local recurrence of pancreatic ductal adenocarcinoma after pancreaticodu… DOI 10.1016/j.surg.2022.02.010 ↗
Shinichi Ikuta · 1 shared paper, 2022 · strength 0.16
- Paper Impact of the aberrant right hepatic artery on local recurrence of pancreatic ductal adenocarcinoma after pancreaticodu… DOI 10.1016/j.surg.2022.02.010 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.